Draft Guidance on Consent by a Legal Representative on Behalf of a Person Not Able to Consent Under the Medicines for Human Use (Clinical Trials) Regulations 2003
London: Medicines and Healthcare Products Regulatory Agency 2003; 19p. [Online]. Available: http://www.mhra.gov.uk/inforesources/publications/mlx287/content. pdf [2004 December 8]
Showing items related by title, author, creator and subject.
Guidance for Industry. Using a Centralized IRB Review Process in Multicenter Clinical Trials. Draft Guidance Unknown creator (United States. Food and Drug Administration [FDA]; Good Clinical Practice Program, Office of the Commissioner [OC]; Center for Drug Evaluation and Research [CDER]; Center for Biologics Evaluation and Research [CBER]; Office of Regulatory Affairs [ORA], 2005-03)